Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Geox SpA (GHH) Stock Price & Analysis

GHH Stock Chart & Stats

€0.25-€0.00(-1.18%)
At close: 1:00 AM GMT+1
€0.275€0.28€0.285€0.2913 Jul16 Jul22 Sep
Day’s Range
EUR 0.25 - EUR 0.25
52-Week Range
EUR 0.23 - EUR 0.35
Previous Close
EUR 0.26
Volume
N/A
Average Volume (3M)
53
Market Cap
EUR 114.05M
Enterprise Value
EUR 386.49M
Total Cash (Recent Filing)
EUR 18.79M
Total Debt (Recent Filing)
EUR 299.36M
Price to Earnings (P/E)
―
Beta
0.71
Next Earnings
Mar 11, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Recovery

The strong 2025 revenue rebound indicates improved demand or commercial execution after a weaker period. Combined with a materially narrower loss, this supports the possibility of continued operating recovery and provides a larger revenue base from which fixed costs can be absorbed.

Solid Gross Margins

Consistently solid gross margins show that Geox retains meaningful product-level economics despite ongoing losses. EBIT moving near break-even suggests this margin base could support operating leverage if revenue remains stronger and the company converts gross profit into sustainable profitability.

Positive Cash Generation

Positive operating and free cash flow demonstrate that the business is generating cash internally rather than relying solely on external funding. This supports ongoing operations and investment, while the history of positive free cash flow provides a useful foundation for financial improvement.

Bears Say

Persistent Losses

Geox has not yet established sustained bottom-line profitability, with losses continuing across the reported period. The narrower 2025 loss is encouraging, but recurring negative earnings reduce internal capital formation and leave the business more exposed if operating improvements stall.

High Leverage

Debt materially exceeds the equity cushion, creating a central solvency and financial-flexibility risk. Even with some debt reduction, the thin capital base can constrain investment and make the company less resilient to weaker trading or the need to fund obligations during a prolonged recovery.

Declining Free Cash Flow

The sharp year-over-year decline in free cash flow weakens the quality of the recent recovery and reduces the cash available for debt reduction, investment, or protection against setbacks. Positive generation remains helpful, but worsening conversion could limit balance-sheet repair over the next several quarters.

Geox SpA News

GHH FAQ

What was Geox SpA’s price range in the past 12 months?
Geox SpA lowest stock price was €0.23 and its highest was €0.35 in the past 12 months.
What is Geox SpA’s market cap?
Geox SpA’s market cap is €114.05M.
When is Geox SpA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Geox SpA’s earnings last quarter?
Geox SpA released its earnings results on Jul 29, 2026. The company reported -€0.012 earnings per share for the quarter.
Is Geox SpA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Geox SpA pay dividends?
Geox SpA does not currently pay dividends.
What is Geox SpA’s EPS estimate?
Geox SpA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Geox SpA have?
Geox SpA has 429,485,700 shares outstanding.
What happened to Geox SpA’s price movement after its last earnings report?
Geox SpA reported an EPS of -€0.012 in its last earnings report. Following the earnings report the stock price went up 0.738%.
Which hedge fund is a major shareholder of Geox SpA?
Currently, no hedge funds are holding shares in DE:GHH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology